Veracyte's Hold Recommendation Maintained by Canaccord Genuity, Analyst Price Forecast Suggests 6.79% Downside

Canaccord Genuity maintains Veracyte (VCYT) with a Hold recommendation, with a one-year price target of $42.94/share, a decrease of 6.79% from its latest closing price. The projected annual revenue for Veracyte is $411MM, a decrease of 16.91%. There are 616 funds reporting positions in Veracyte, with an average portfolio weight of 0.18% and total shares owned by institutions increasing by 2.79%.